Skip to main content
. 2009 Mar 5;10:7. doi: 10.1186/1471-2369-10-7

Table 3.

Haemodynamic consequences of using citric instead of acetic acid in dialysis fluids II.

Acetate (A) Citrate (C) Citrate (C+) P(Avs.C) P(Avs.C+)
Systolic BP (mmHg) max.decrease 19.2 ± 9.61 25.6 ± 10.98 23.4 ± 13.43 < 0.01 ns
max.increase 13.96 ± 8.28 9.07 ± 7.84 11.01 ± 8.32 < 0.05 ns
Diastolic BP (mmHg) max.decrease 10.60 ± 4.06 12.18 ± 5.13 10.68 ± 5.99 ns ns
max.increase 7.42 ± 5.56 7.33 ± 5.54 7.95 ± 5.03 ns ns
Blood volume # (%) max.decrease 6.05 ± 4.21 4.81 ± 3.51 6.47 ± 3.88 ns ns
max increase 0.99 ± 0.95 1.21 ± 1.26 0.44 ± 0.70 ns < 0.05
Heart rate # (beat/min) max.decrease 8.04 ± 5.99 7.79 ± 5.76 7.81 ± 6.92 ns ns
max increase 4.03 ± 3.21 3.27 ± 2.95 4.03 ± 4.28 ns ns
Stroke volume (ml) max.decrease 17.20 ± 9.78 19.62 ± 10.41 14.90 ± 16.65 ns ns
max.increase 28.14 ± 15.22 28.26 ± 32.24 23.04 ± 23.97 ns ns
Peripheral resistence max.decrease 973.60 ± 571.25 485.30 ± 267.25 410.37 ± 330.91 < 0.001 < 0.001
(dyne.sec.cm-5) max.increase 904.73 ± 376.18 791.69 ± 464.17 741.30 ± 528.75 ns ns

Blood volume, blood pressure (BP), heart rate, stroke volume and peripheral resistance fluctuations during dialysis using acetate dialysate (A) vs. citrate dialysate with (C+) or without (C) calcium supplementation.